1. Research Objectives and Assumptions

   • Research Objectives
   • Assumptions
   • Abbreviations

2. Market Purview

   • Report Description
     • Market Definition and Scope
   • Executive Summary
     • Market Snapshot, By Treatment Type
     • Market Snapshot, By Type
     • Market Snapshot, By Geography
   • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

   • Market Dynamics
     • Increasing prevalence of onychomycosis around the world
     • Availability of alternative treatment options
     • Rise in demand for safe/effective onychomycosis treatment
   • Impact Analysis
   • Key Highlights
   • Regulatory Scenario
   • Product launch/Approvals
   • PEST Analysis
   • PORTER’s Analysis
   • Merger and Acquisition Scenario

4. Global Onychomycosis Treatment Market, By Treatment Type, 2020-2033, (USD Mn)

   • Introduction
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2020 – 2033
     • Segment Trends
   • Drugs
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
   • Laser Therapy
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
   • Photodynamic Therapy
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)

5. Global Onychomycosis Treatment Market By Type, 2020-2033, (USD Mn)

   • Introduction
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2020 – 2033
     • Segment Trends
   • Distal Subungual Onychomycosis
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
   • White Superficial Onychomycosis
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
   • Proximal Subungual Onychomycosis
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
   • Other Types
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)

6. Global Onychomycosis Treatment Market By Geography, 2020-2033, (USD Mn)

   • Introduction
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2020 – 2033
     • Segment Trends
   • North America
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2033, (USD Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2033, (USD Mn)
       • U.S.
       • Canada
   • Europe
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2033, (USD Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2033, (USD Mn)
       • U.K.
       • Germany
       • France
       • Rest of Europe
   • Asia Pacific
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2033, (USD Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2033, (USD Mn)
       • China
       • Japan
       • Australia
       • India
       • ASEAN
       • South Korea
       • Rest of Asia Pacific
   • Latin America
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2033, (USD Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2033, (USD Mn)
       • Mexico
       • Brazil
       • Rest of Latin America
   • Middle East
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2033, (USD Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2033, (USD Mn)
       • GCC
   • Africa
     
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2033, (USD Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2033, (USD Mn)
       • South Africa
       • Rest of Middle East, and Africa

7. Competitive Landscape

   • Lumenis Ltd.
     • Company Highlights
     • Product Portfolio
     • Key Developments
     • Financial Performance
     • Strategies
   • Cipla Ltd.
     • Company Highlights
     • Product Portfolio
     • Key Developments
     • Financial Performance
     • Strategies
   • Bayer AG
     • Company Highlights
     • Product Portfolio
     • Key Developments
     • Financial Performance
     • Strategies
   • Johnson & Johnson
     • Company Highlights
     • Product Portfolio
     • Key Developments
     • Financial Performance
     • Strategies
   • Moberg Pharma AB
     • Company Highlights
     • Product Portfolio
     • Key Developments
     • Financial Performance
     • Strategies
   • Pfizer Inc.
     • Company Highlights
     • Product Portfolio
     • Key Developments
     • Financial Performance
     • Strategies
   • Novartis
     • Company Highlights
     • Product Portfolio
     • Key Developments
     • Financial Performance
     • Strategies
   • Galderma SA
     • Company Highlights
     • Product Portfolio
     • Key Developments
     • Financial Performance
     • Strategies
   • Dr. Reddys Laboratories Ltd.
     • Company Highlights
     • Product Portfolio
     • Key Developments
     • Financial Performance
     • Strategies
   • Medimetriks Pharmaceuticals Inc.
     • Company Highlights
     • Product Portfolio
     • Key Developments
     • Financial Performance
     • Strategies
   • Bausch Health Companies Inc. (Valeant Pharmaceuticals Inc.)
     • Company Highlights
     • Product Portfolio
     • Key Developments
     • Financial Performance
     • Strategies
   • Analyst Views

8. Section

   • Research Methodology
   • About us